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Question:  In women  with  primary  dysmenorrhoea,  what  is the  effect  of physiotherapeutic  interventions
compared  to  control  (either  no  treatment  or placebo/sham)  on  pain  and  quality  of  life?  Design:  System-
atic  review  of  randomised  trials  with  meta-analysis.  Participants:  Women  with  primary  dysmenorrhea.
Intervention:  Any  form  of physiotherapy  treatment.  Outcome  measures:  The  primary  outcome  was
menstrual  pain  intensity  and  the  secondary  outcome  was  quality  of  life. Results:  The  search  yielded  222
citations.  Of  these,  11  were  eligible  randomised  trials  and  were  included  in  the  review.  Meta-analysis
revealed  statistically  signiﬁcant  reductions  in  pain  severity  on  a  0–10  scale  from  acupuncture  (weighted
mean  difference  2.3,  95% CI 1.6  to  2.9)  and  acupressure  (weighted  mean  difference  1.4,  95% CI  0.8  to
1.9),  when  compared  to a control  group  receiving  no treatment.  However,  these  are  likely  to  be placebo
effects  because  when  the  control  groups  in acupuncture/acupressure  trials  received  a  sham  instead  of
no treatment,  pain  severity  did not  signiﬁcantly  differ  between  the  groups.  Signiﬁcant  reductions  in  pain
intensity  on  a 0–10  scale  were  noted  in  individual  trials  of heat  (by  1.8, 95%  CI  0.9 to 2.7),  transcutaneous
electrical nerve  stimulation  (2.3,  95%  CI  0.03  to 4.2), and  yoga  (3.2,  95% CI 2.2 to  4.2). Meta-analysis  of
two  trials  of spinal  manipulation  showed  no  signiﬁcant  reduction  in pain.  None  of  the  included  studies
measured  quality  of  life.  Conclusion:  Physiotherapists  could  consider  using  heat,  transcutaneous  elec-
trical nerve  stimulation,  and  yoga  in  the  management  of primary  dysmenorrhea.  While  beneﬁts  were
also  identiﬁed  for  acupuncture  and  acupressure  in  no-treatment  controlled  trials,  the  absence  of  signif-
icant effects  in sham-controlled  trials  suggests  these  effects  are  mainly  attributable  to  placebo  effects.
[Kannan  P, Claydon  LS (2014)  Some  physiotherapy  treatments  may  relieve  menstrual  pain  in women
with  primary  dysmenorrhea:  a systematic  review.  Journal  of Physiotherapy  60:  13–21]
© 2014  Australian  Physiotherapy  Association.  Published  by Elsevier  B.V.  This  is  an  open  access  article
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Primary dysmenorrhoea is deﬁned as cramping pain in the lower
bdomen that occurs just before or during menstruation with-
ut identiﬁable pelvic pathology.1 Secondary associated symptoms
nclude nausea, vomiting, fatigue, back pain, headaches, dizziness,
nd diarrhoea.2 Primary dysmenorrhoea has been reported as the
eading cause of recurrent absenteeism from school or work in ado-
escent girls and young women, and is considered to be a common
isorder among women of reproductive age.3 A survey of 1266
emale university students found the total prevalence of primary
ysmenorrhoea to be 88%, with 45% of females having painful men-
truation in each menstrual period and 43% of females having some
ainful menstrual periods.4Excessive production and release of prostaglandins during
enstruation by the endometrium causes hyper-contractility of
he uterus, leading to uterine hypoxia and ischaemia, which are
elieved to cause the pain and cramps in primary dysmenorrhoea.3
ttp://dx.doi.org/10.1016/j.jphys.2013.12.003
836-9553/© 2014 Australian Physiotherapy Association. Published by Elsevier B.V. This is 
icenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Based on this understanding, pharmacological therapies for
primary dysmenorrhoea focus on alleviating menstrual pain
and relaxing the uterine muscles by using non-steroidal anti-
inﬂammatory drugs (NSAIDs) or oral contraceptive pills.5 A
survey of 560 female students from three medical colleges
in India reported that 87% of those with dysmenorrhea also
sought treatment.6 Among the women who sought treatment,
73% took analgesics and 58% had physiotherapy management,
primarily heat treatment. Managing dysmenorrhea with NSAIDs
and oral contraceptives is reported to be associated with side
effects such as nausea, breast tenderness, intermenstrual bleed-
ing, and hearing and visual disturbances7 and in about 20 to
25% of women, menstrual pain has been shown to be inade-
quately controlled by NSAIDs alone.8 Therefore, ﬁnding an effective
non-pharmacological method for relieving symptoms of primary
dysmenorrhoea has a signiﬁcant potential value.
Non-pharmacological, non-invasive, and minimally invasive
interventions that have been proposed for obtaining relief from
an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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ysmenorrhea symptoms include acupuncture and acupressure,
iofeedback, heat treatments, transcutaneous electrical nerve
timulation (TENS), and relaxation techniques.7 Systematic reviews
nd meta-analyses have been conducted to determine the efﬁcacy
f individual physiotherapy interventions on primary dysmenor-
hoea. In 2009, a systematic review of trials of TENS reported that
igh-frequency TENS was effective for the treatment of primary
ysmenorrhoea.9 In 2009, a Cochrane systematic review evaluated
hree randomised trials on spinal manipulation and concluded that
here was no evidence to suggest that spinal manipulation was
ffective.10 In 2008, a systematic review of randomised trials of acu-
ressure for primary dysmenorrhoea concluded that acupressure
lleviates menstrual pain.11 Though many reviews have evaluated
he efﬁcacy of individual physiotherapy interventions for primary
ysmenorrhoea, to our knowledge no reviews have been done to
etermine the efﬁcacy of physiotherapy modalities in the man-
gement of pain and quality of life in primary dysmenorrhoea. In
ddition, these reviews require updating because new trials of acu-
ressure, acupuncture, and yoga have been published since 2010.
herefore, the research question for this systematic review was:
In women with primary dysmenorrhea, do physiotherapy inter-
ventions reduce pain and improve quality of life compared to a
control condition of either no treatment or a placebo/sham?
ethods
dentiﬁcation and selection of studies
A search of the electronic databases CINAHL, PEDro, EMBASE,
eb of Science, Ovid Medline, and AMED was conducted. The pub-
ication period searched was from database inception to June 2012.
he search strategy for each database is presented in Appendix 1 of
he eAddenda. No additional manual searches were performed. Two
eviewers independently applied the inclusion criteria presented in
ox 1 to all the retrieved studies, and any that clearly did not fulﬁl
hese criteria were excluded. If there was any uncertainty regarding
he eligibility of the study from the title and abstract, the full text
as retrieved and assessed for eligibility. The full text version of
ll included trials was used for data extraction and methodological
uality assessment independently by both the authors. Disagree-
ents were resolved by discussion between the reviewers until
onsensus was reached. The authors were contacted for any missing
ata in the included studies.
Box 1. Inclusion criteria.
Design
• Randomised controlled trials
Participants
• Women with primary dysmenorrhea
Interventions
• Acupuncture and acupressure
• Manual therapy, including spinal manipulation
• Electrotherapy, including transcutaneous electrical nerve
stimulation
• Massage
• Therapeutic exercise
Outcome measures
• Primary: pain intensity as measured by the VAS and NRS
• Secondary: quality of life
Comparisons
• Physiotherapy intervention versus no treatment
• Physiotherapy intervention versus placebo or sham control interventions in primary dysmenorrhea
Assessment of characteristics of trials
Quality
The methodological quality of each included trial was assessed
by two  independent reviewers using the PEDro scale. Trials were
not excluded on the basis of quality, although quality was  taken
into account when interpreting the results. Each item on the scale
was scored as either ‘yes’ or ‘no’ and the number of items scored
as ‘yes’ (excluding the ﬁrst item, which relates to external validity)
was summed to give a total score out of 10. Trials scoring six or
more were considered to be of high quality and trials scoring ﬁve
or less were considered to be of low quality.
For rating the quality of the evidence, the grading of recom-
mendations assessment, development, and evaluation (GRADE)
approach was used. According to this system, the quality of evi-
dence is assessed by rating the outcomes of the trials included in
the review. The quality is then categorised as ‘high,’ ‘moderate,’
‘low,’ or ‘very low’.12 Evidence based on randomised trials begins
as high-quality evidence and is downgraded for the following rea-
sons: limitations in conduct and analysis (ie, risk of bias) of the
studies; imprecision of the summary of the estimate of effect; incon-
sistency of the results across the available studies; indirectness or
poor applicability of the evidence with respect to the populations,
interventions, and settings where the proposed intervention may
be used;12 and evidence of publication bias.
Downgrading for risk of bias could occur for: lack of alloca-
tion concealment; non-blinding of participants, personnel, and
outcome assessors; incomplete outcome data; selective outcome
reporting; or other sources of bias.13 Non-blinding of participants
and therapists was considered to be a major limitation and also
resulted in downgrading. In studies with self-reported outcomes,
lack of assessor blinding was considered to be a minor limitation
and was  not downgraded. For judging precision, the clinical deci-
sion threshold boundary for absolute difference was  set at 1%. If
this boundary was met, imprecision was not downgraded. If the
absolute size excluded this boundary and if the sample size was
small, imprecision was downgraded.14 To inform this decision, the
optimum information size was  calculated to be 26 in each group,
assuming  ˛ of 0.05 and  ˇ of 0.02. The difference in means between
groups was  taken as 1.4 cm,  based on previous studies. If assess-
ment of consistency of results indicated heterogeneity between
studies, random-effects models were used for meta-analysis where
appropriate. When judging directness,  studies were downgraded if
patients or interventions differed from those of interest.15 Evidence
was rated down for publication bias if the individual trials were
commercially funded.16 The overall quality of evidence was then
based on the lowest quality rating for the outcome.17
Design
Only randomised trials were eligible, including crossover trials
if outcome data were available for each intervention prior to the
crossover. Studies published in languages other than English and
Swedish were excluded.
Participants
The age and pain severity of the participants with primary dys-
menorrhoea were recorded to describe the trials. Trials involving
participants with secondary dysmenorrhoea, that is, individuals
with an identiﬁable pelvic pathology or chronic pelvic pain, were
excluded.
Interventions
Trials that compared different forms of the same treatment (eg,
different modes of TENS) were excluded. The effect of physiother-
apy had to be distinguishable from the effects of other treatment.
For example, where participants were permitted to take analgesics
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ata analysis
For each included study, two reviewers independently extracted
he sample size, details of the intervention and control, time points
f outcome measurement, and pre- and post-intervention means.
here possible, data presented in other formats were converted
o mean and SD for inclusion in meta-analysis. Meta-analysis was
arried out for pain intensity immediately post-intervention using
eview Manager 5.18 Separate meta-analyses were completed for
o-treatment-controlled trials and for placebo/sham-controlled
rials. Weighted mean differences were calculated for the analyses.
n the meta-analyses and throughout the Results section, all data
rom pain scales were converted to a 10-point scale. A ﬁxed-effect
odel was used where heterogeneity was minimal (as shown by
he 2 and I2 values) and otherwise, a random-effects model was
sed. Statistical signiﬁcance was set at p ≤ 0.05.
esults
low of studies through the review
The initial searches identiﬁed 222 potentially relevant papers.
he ﬂow of papers through the process of assessment of eligibility is
resented in Figure 1, including the reasons for exclusion of papers
t each stage of the process. The speciﬁc papers identiﬁed within
ach database by the search strategy are presented in Appendix 1
See eAddenda for Appenidx 1). We  contacted study authors when
Papers screened by abstract (n = 57) 
Studies included in the review (n= 11) 
Excluded after screening of abstract (n = 20) 
 ineligible intervention (n= 8) 
 only active treatments compared (n = 6)
 no eligible outcome (n = 3)
 participants included somewomen with 
secondary dysmenorrhoea (n = 2) 
 not a randomised trial (n = 1) 
Papers retrieved by the search(n = 222) 
 AMED (n =1) 
 CINAHL (n =6) 
 Embase (n =62) 
 PEDro (n =40) 
 Ovid Medline (n =20) 
 Web of Science (n =93) 
Duplicates (n= 86) 
Potentially relevant papers retrieved for 
evaluation of full text (n= 37) 
Excluded after screening of title (n = 79) 
 ineligible intervention (n = 31)
 systematic reviews (n=25) 
 ineligi ble  parti cipants  (n=23) 
Excluded after screening of full text (n = 26) 
 effect of physiotherapy intervention could not 
be distinguished (n = 10) 
 ineligible study design (n = 8) 
 no eligible outcome data (n = 6) 
 non-physiotherapy component to the 
intervention (n= 1) 
 only active treatments compared (n=1) 
Figure 1. Flow of studies through the review.h 15
data were not reported in the format that allowed inclusion in the
review.7 The data could not be obtained in a suitable format, so it
was excluded.
Characteristics of included trials
In total, the 11 included trials contributed data on 793 partici-
pants. The quality of the included trials is presented in Table 1, the
grade of evidence for each outcome is presented in Table 2, and a
summary of the included trials is presented in Table 3.
Quality
The methodological quality of the included trials ranged from
low to high, with a mean PEDro36 score of 6.5 out of 10, as presented
in Table 1. Six trials3,19–23 were methodologically high-quality tri-
als with scores ≥6. The individual PEDro items satisﬁed by fewer
than half the trials were concealed allocation (ﬁve trials) and those
related to blinding, which is discussed in more detail in the next
section.
GRADE
As identiﬁed by the PEDro scale, GRADE assessment of risk of bias
showed that only ﬁve trials blinded participants,3,21–24 two  trials
blinded therapists,19,23 and four trials blinded assessors.3,19–21 Acu-
pressure and yoga were the only interventions where the available
trials allowed good precision. No inconsistency, serious indirectness,
or publication bias was  identiﬁed. The completeness of outcome
data for each outcome was adequately described in all the included
studies. No other limitations, such as stopping early for beneﬁt or
use of unvalidated outcome measures, were identiﬁed in any of the
included studies. The summary of ﬁndings and evidence proﬁle are
presented in Table 2. The overall grade of the evidence obtained
for the outcome menstrual pain for acupuncture and acupressure
trials was  ‘moderate.’ Spinal manipulation and TENS trials obtained
‘very low’ grades, while heat therapy and yoga trials obtained ‘low’
grades.
Participants
The sample sizes contributed by the included trials ranged from
20 to 144. The mean age of participants in the included trials ranged
from 17 to 34 years.
Interventions
One trial2 compared the effectiveness of TENS to a placebo pill,
two trials20,21 compared the effect of spinal manipulation to sham
manipulation, and one trial19 compared the effect of continuous
low-level heat to a sham heat patch. One trial25 compared the
effect of yoga to no treatment. Two  trials3,23 each compared the
effect of acupuncture to two  controls: sham treatment (ie, applied
to non-acupoints), and no treatment. Four trials investigated the
effect of acupressure, with two of these trials applying no treat-
24,26ment to the control group and two using sham acupressure as
a control.22,27
Outcome measures
Two  trials measured pain intensity on a numerical rating scale,
and nine trials measured the pain intensity on a visual analogue
scale (VAS). Although some trials also measured composite scores
of pain and other menstrual symptoms, none of the included trials
measured a validated quality-of-life score.
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tistical signiﬁcance between the groups, with a weighted mean
difference of 1.9 (95% CI −0.4 to 4.2), as presented in Figure 8. A
T
Pigure 2. Forest plot of weighted mean difference (95% CI) for pain intensity for
cupuncture versus no treatment.
ffect of intervention
cupuncture versus no treatment
Data were pooled from two methodologically high-quality tri-
ls, providing moderate grade evidence comparing the effect of
cupuncture with a no-treatment control.3,23 Both trials measured
ain intensity on a VAS. The analysis showed a signiﬁcant beneﬁt
f acupuncture in reducing pain compared to control immediately
fter treatment, with a weighted mean difference of 2.3 (95% CI
.6 to 2.9), as presented in Figure 2. A more detailed forest plot is
resented in Figure 3, which is available in the eAddenda.
cupuncture versus sham
The same two trials also compared the analgesic effect of
cupuncture with placebo.3,23 When pain VAS data from the tri-
ls were meta-analysed, the weighted mean difference tended to
avour the acupuncture group by 1.8; this was not statistically
igniﬁcant (95% CI −0.1 to 3.6), as presented in Figure 4. A more
etailed forest plot is presented in Figure 5, which is available in
he eAddenda.
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igure 4. Forest plot of weighted mean difference (95% CI) for pain intensity for
cupuncture versus sham acupuncture.
able 1
EDro scores of included trials (n = 11).
Trial Random
allocation
Concealed
allocation
Groups
similar at
baseline
Participant
blinding
Therap
blindin
Akin 200119 Y Y Y N Y 
Chen  200426 Y N Y N N 
Chen  201024 Y Y N Y N 
Hondras 199920 Y Y Y N N 
Kokjohn 199221 Y N Y Y N 
Ma  20103 Y Y Y Y N 
Mirbagher-Ajorpaz 201122 Y N Y Y N 
Neighbors 19872 Y N Y N N 
Pouresmail 200227 Y N N N N 
Rakhshaee 201125 Y N Y N N 
Shi  201123 Y Y Y Y Y Figure 6. Forest plot of weighted mean difference (95% CI) for pain intensity for
acupressure versus no treatment.
Acupressure versus no treatment
Data were pooled from two trials comparing the use of acupres-
sure with control.24,26 Both trials measured pain intensity on the
VAS. The trials provided were methodologically low quality, provid-
ing low-grade evidence. The pooled analysis showed a signiﬁcant
beneﬁt of acupressure compared to no treatment, with a weighted
mean difference of 1.4 (95% CI 0.8 to 1.9), as presented in Figure 6. A
more detailed forest plot is presented in Figure 7, which is available
in the eAddenda.
Acupressure versus sham
Two trials compared the effects of acupressure with sham acu-
pressure as a control.22,27 The trials were methodologically low
quality, providing low-grade evidence. The study showed no sta-more detailed forest plot is presented in Figure 9, which is available
in the eAddenda. Note that the trial by Mirbagher-Ajorpaz et al22
Mean difference, 95% Cl
Mirbagher-Ajorpaz 2011
Poursemail 2002
Pooled
-10 -5 0 5 10
Favours experimental Favours control
Figure 8. Forest plot of weighted mean difference (95% CI) for pain intensity for
acupressure versus sham acupressure.
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Point
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(0–10)
Y Y Y N Y 8
N N Y Y Y 5
N N Y N Y 5
Y Y Y Y Y 8
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Table 2
GRADE evidence proﬁle (EP) and summary of ﬁndings (SoF).
Quality assessment Summary of ﬁndings
Number of
participants and
number of studies
Risk of bias Inconsistency Indirectness Imprecision Publication
bias
Overall quality
of evidence
Study event rates (%) Relative effect
(95% CI)
Anticipated absolute effects
With control With
intervention
Risk with
control
Risk difference with
intervention (95% CI)
Manipulation vs. sham – Outcome - menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
182
2  studies20,21
Very seriousa No serious
inconsistency
No serious
indirectness
No serious
imprecision
Undetected LOWa
due to risk of
bias
– – – The mean
menstrual pain in
the intervention
group was 0.6
lower (1.7–0.4
lower)
Acupressure vs. no treatment – outcome-menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
203
2  studies 24,26
Very seriousb No serious
inconsistency
No serious
indirectness
No serious
imprecision
Undetected LOWb
due to risk of
bias
– – – The mean
menstrual pain in
the intervention
group was  1.4
lower (1.9–0.8
lower)
Acupuncture vs. no treatment – outcome-menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
46
2  studies 3,23
No serious
risk of biasc
No serious
inconsistency
No serious
indirectness
Seriousd Undetected
MODERATEd
due to
imprecision
– – – The mean
menstrual pain in
the intervention
group was  2.3
lower (2.9–1.6
lower)
Heat therapy vs. sham – outcome-menstrual pain (measured with: NRS; range of scores: 0–100; Better indicated by lower values)
40
1  study19
Seriouse No serious
inconsistencyf
No serious
indirectness
Seriousd Undetected
LOWd,e due
to risk of bias
and
imprecision
– – – The mean
menstrual pain
in the control
group was 4.7
The mean
menstrual pain in
the intervention
group was  1.8
lower (2.7–0.9
lower)
TENS vs. placebo pill – outcome-menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
20
1  study2
Very seriousg No serious
inconsistencyf
No serious
indirectness
Seriousd Undetected VERY
LOWd,g due
to risk of bias
and
imprecision
– – – The mean
menstrual pain
in the control
group was 4.1
The mean
menstrual pain in
the intervention
group was 2.3
lower (4.6 to 0.03
lower)
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Table 2 (Continued)
Quality assessment Summary of ﬁndings
Number of
participants and
number of studies
Risk of bias Inconsistency Indirectness Imprecision Publication
bias
Overall quality
of evidence
Study event rates (%) Relative effect
(95% CI)
Anticipated absolute effects
With control With
intervention
Risk with
control
Risk difference with
intervention (95% CI)
Acupuncture vs. sham – outcome-menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
46
2  studies3,23
No serious
risk of biasc
No serious
inconsistency
No serious
indirectness
Seriousd Undetected
MODERATEd
due to
imprecision
– – – The mean
menstrual pain in
the intervention
group was 1.8
lower (3.6 lower to
0.1 higher)
Acupressure vs. sham – outcome-menstrual pain (measured with: VAS; range of scores: 0–10; better indicated by lower values)
174
2  studies22,27
Very serioush No serious
inconsistency
No serious
indirectness
No serious
imprecision
Undetected LOWh
due to risk of
bias
– – – The mean
menstrual pain in
the intervention
group was 1.9
lower (4.2 lower to
0.4 higher)
Yoga vs. no treatment – outcome-menstrual pain (measured with: VAS; better indicated by lower values)
92
1  study25
Very seriousi No serious
inconsistencyf
No serious
indirectness
No serious
imprecision
Undetected LOWi
due to risk of
bias
– – – The mean
menstrual pain
in the control
group was 2.5
The mean
menstrual pain in
the intervention
group was 3.2
lower (4.2 lower to
2.2 higher)
VAS = visual analogue scale, NRS = numeric rating scale, OIS = optimum information size, TENS = transcutaneous electrical nerve stimulation.
a Very serious risk of bias: allocation not concealed, therapist not blinded, and analysis not performed on an intention-to-treat basis in.21 Participants and therapist not blinded in Hondras et al20
b Very serious risk of bias: allocation not concealed participants and therapists not blinded in.26 Therapist not blinded in Chen and Chen.24
c No serious risk of bias, not downgraded: in Ma et al,3 acupuncturist was  not blinded but the imaging technician was  blinded and separated from acupuncturist.
d Clinical decision threshold and OIS criterion not met.
e Serious risk of bias: Participants not blinded in Akin et al19
f Not applicable – one trial.
g Very serious risk of bias: allocation not concealed, participants and therapists not blinded, and analysis not performed on an intention-to-treat basis, in Neighbors et al2
h Very serious risk of bias: allocation not concealed, and therapist not blinded in Pouresmail and Ibrahimzadeh27 and Mirbagher-Ajorpaz et al22 In addition, participants were not blinded in.27
i Very serious risk of bias: allocation not concealed, therapist and participant not blinded, and analysis not performed on an intention-to-treat basis in Rakshaee25.
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Table  3
Summary of included trials (n = 11).
Trial Participantsa,b,c Experimental Control Pain scale
Akin 200119 n = Exp 20, Con 20
Age (yr) = Exp 33 (6), Con 34 (7)
Pain (0–10) = Exp 7.3 (1.4), Con 6.9 (1.4)
Heat patch and placebo
tablet
Sham (unheated) patch
and placebo tablet
NRS (0–100)
Chen 200426 n = Exp 35, Con 34
Age (yr) = Exp 18 (1), Con 18 (2)
Pain (0–10) = Exp 6.5 (1.8), Con 6.5 (1.5)
Acupressure on SP6
point
No treatment VAS (10 cm)
Chen 201024 n = Exp 1 30, Exp 2 33, Exp 3 36, Con 35
Age (yr) = Exp 1 17 (1), Exp 2 17 (2), Exp 3 17 (2),
Con 17 (1)
Pain (0–10) = Exp 1 5.5 (1.6), Exp 2 5.1 (1.6), Exp 3
4.9 (1.8), Con 5.5 (1.4)
Acupressure on LI4
point
Acupressure on ST36
point
Acupressure on LI4 and
SP6
No treatment VAS (10 cm)
Hondras 199920 n = Exp 69, Con 69
Age (yr) = Exp 31, Con 30, (range 18–45)
Pain (0–10) = Exp 4.3, Con 3.8
Spinal manipulation Sham manipulation, ie,
low force manoeuvre
VAS (100 mm)
Kokjohn 199221 n = Exp 23, Con 21
Age (yr) = 30, range 20–49
Pain (0–10) = Exp 5.9, Con 6.0
Spinal manipulation Sham manipulation VAS (10 cm)
Ma  20103 n = Exp 1 13, Exp 2 14, Con 1 12, Con 2 13
Age (yr) = Exp 1 22 (2), Exp 2 22 (2), Con 1 22 (2),
Con 2 23 (3)
Pain (0–10) = Exp 1 6.3 (1.4), Exp 2 5.6 (0.9), Con 1
5.9 (1.4), Con 2 6.3 (1.3)
Electroacupuncture on
SP6 point
Electroacupuncture on
GB39 point
Sham
electroacupuncture, ie,
on non-acupoints
No treatment
VAS (100 mm)
Mirbagher-Ajorpaz 201122 n = Exp 15, Con 15
Age (yr) = 22 (2)
Pain (0–10) = Exp 5.8 (1.6), Con 5.5 (1.8)
Acupressure on SP6
point
Sham acupressure, ie,
touch but no pressure
on SP6 point
VAS (10 cm)
Neighbors 19872 n = Exp 10, Con 10
Age (yr) = 25, range 19–38
Pain (0–10) = Exp 4.2 (1.6), Con 4.5 (1.6)
Acupuncture-like TENS Placebo pill VAS (10 cm)
Pouresmail 200227 n = Exp 72, Con 72
Age (yr) = range 14–18
Pain (0–10) = Exp 6.1 (SD 1.5), Con 6.0 (SD 1.7)
Acupressure to LI4,
SP15, ST36, SP6 and
LR3 points
Sham acupressure, ie,
on non-acupoints
VAS (10 cm)
Rakshaee 201125 n = Exp 50, Con 42
Age (yr) = Exp 21, Con 20
Pain (0–10) = Exp 8.3, Con 7.8
Yoga No treatment NRS (0–3)
Shi et al 201123 n = Exp 10, Con1 10, Con2 10
Age (yr) = Exp 22 (1), Con1 22 (2), Con2 22 (3)
Pain (0–10) = Exp 6.0 (1.1), Con1 5.7 (1.0), Con 2 5.7
(1.3)
Acupuncture on SP6
point
Sham acupuncture, ie,
on non-acupoint
No treatment
VAS (100 mm)
NRS = numerical rating scale, TENS = transcutaneous electrical nerve stimulation, VAS = visual analogue scale.
a Age and pain values are mean (SD) unless otherwise stated.
b The number of participants stated is the number that provided outcome data.
c Pain values are converted to 0–10 scale regardless of how they were recorded.
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ligure 10. Forest plot of weighted mean difference (95% CI) for pain intensity for
pinal manipulation versus sham spinal manipulation.
ssessed pain intensity up to 3 hours after treatment and effects
ere increasingly better, with peak effect reached at 3 hours after
reatment.anipulation versus sham
Two trials compared the effect of spinal manipulation with sham
anipulation as a control.20,21 The trials were methodologically
ow quality, providing low-grade evidence. The pooled analysisshowed a non-signiﬁcant beneﬁt of manipulation, with a weighted
mean difference of 0.6 (95% −0.4 to 1.7), as presented in Figure 10.
A more detailed forest plot is presented in Figure 11, which is avail-
able in the eAddenda.
Heat versus sham
One trial compared the effect of a heat pad with a sham
(unheated) pad.19 The trial showed a signiﬁcant beneﬁt from heat
compared to placebo, with a mean difference of 1.8 (95% CI 0.9
to 2.7).
TENS versus placebo pill
One trial compared the analgesic effect of TENS with a placebo
pill.2 The trial showed a signiﬁcant effect of TENS compared to
placebo pill immediately after treatment, with a mean difference
of 2.3 (95% CI 0.03 to 4.6).Yoga versus no treatment
One trial compared the analgesic effect of yoga with no treat-
ment control.25 Note that the data collected using a 0–3 scale are
converted to a 0–10 scale here. The study showed a signiﬁcant effect
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f yoga compared to control at 1 month following treatment, with
 mean difference of 3.2 (95% CI 2.2 to 4.2).
iscussion
This systematic review identiﬁed statistically signiﬁcant reduc-
ions in pain severity due to several physiotherapy interventions. It
s important to interpret the result for each physiotherapy interven-
ion carefully, considering the extent and quality of the evidence
btained, the details of the interventions provided, the estimates
f the mean effect on pain obtained derived from the data, and
hether the conﬁdence intervals around those estimates include
linically trivial or clinically worthwhile effects.
Among the acupuncture and acupressure trials, we were able to
eta-analyse trials where the control group received no treatment
eparately from placebo- and sham-controlled trials. Comparison
f these meta-analyses revealed an interesting pattern. Meta-
nalysis of the no-treatment controlled trials indicated signiﬁcant
eductions in pain intensity due to acupuncture (by 2.3) and acu-
ressure (by 1.4) on a 0–10 scale. However, the meta-analyses for
oth acupuncture and acupressure were less promising when the
ontrol arm received a sham, with both pooled analyses showing
o statistically signiﬁcant differences between groups. This sug-
ests that the effects of acupuncture and acupressure are mainly
ttributable to placebo effects.
It is difﬁcult to interpret the relevance of the speciﬁc acupoints
sed. Seven of the 10 experimental interventions in the acupunc-
ure and acupressure trials used the SP6 (Sanyinjiao) acupoint,
hich is located approximately 4 cm above the medial malleo-
us, at the posterior border of the medial aspect of the tibia.22
ost researchers select this because it is the acupoint of choice
n gynaecology.26 It is also easy to locate and apply pressure to
P6 without a clinician’s assistance. Among the acupuncture tri-
ls, the same results were obtained when different acupoints were
sed (see Figure 2), but different results were obtained when the
ame acupoints were used (see Figure 4). In contrast, the forest
lot of the no-treatment-controlled trials of acupressure shows a
ange of effects achieved using four different acupoint locations
see Figure 6).
It is also difﬁcult to interpret the relevance of the speciﬁc char-
cteristics of the sham acupuncture. The needling regimens were
imilar to the active intervention, except that Ma  et al3 did not
se evoke De Qi (needle sensation; stimulation of A ﬁbres evok-
ng soreness and/or a motor response ‘needle grasp’). Ma et al3 did
ot specify their non-acupoints, but Shi et al23 used a non-meridian
cupoint located on the lateral side of lower leg. It is now recognised
hat needling a few cm away from the acupuncture point may  not
e a credible placebo.28,29 A recent trial investigating the reliability
f acupuncturists in acupuncture point location suggests that there
as up to a 6-cm difference in acupuncture point location between
he acupuncturists. Neither study used Streitberger placebo nee-
les, which retract – giving minimal to no stimulation.30
The mean estimate of 2.3 reported in the meta-analysis of trials
f acupuncture versus no treatment exceeds the clinically signiﬁ-
ant difference of 2 on the 0–10 scale.31 However, the conﬁdence
ntervals around this and the other acupuncture/pressure meta-
nalyses extend below this threshold, so current evidence does not
xclude the possibility that the true effects of these interventions –
ven when supplemented by placebo effects – may  be clinically
rivial.
Our meta-analysis of sham-controlled acupressure trials contra-
icts the systematic review by,11 which reported that acupressure
lleviates menstrual pain. This discrepancy appears due to different
nclusion criteria allowing different trials to be included.11 included
 sham-controlled, no treatment-controlled or pharmacological- or interventions in primary dysmenorrhea
non-pharmacological-controlled trials. Their review had a trial
where acupressure was  compared to ibuprofen and a sham-
controlled trial published in Farsi.
Meta-analysis of the two trials of spinal manipulation did not
identify a signiﬁcant effect on pain overall. One of the two trials did
achieve a statistically signiﬁcant beneﬁt, but as the interventions
applied in both trials were similar and both used sham manipula-
tion as a control, it is difﬁcult to attribute this to anything other
than random variation. Therefore, the result of the meta-analysis
provides the best answer: if there is any effect, it is clinically triv-
ial. A similar result was reported by Proctor et al,10 although that
review also allowed the inclusion of data about the chiropractic
Toftness adjustment technique.
Heat caused a signiﬁcant reduction in pain, although this result
was derived from only one trial with 40 participants.19 This was
achieved with a 180-cm2 heat patch capable of supplying 38.9 ◦C
heat for 12 hours per day for 3 days. As noted in Table 2, both groups
also received a placebo tablet (because other participants in the trial
received ibuprofen). Therefore, even if participants recognised that
their patch was unheated, the placebo tablet may  have helped to
control for placebo effects. The reduction in pain of 1.8 is close to the
clinically worthwhile threshold of 2,31 so further data in this area
would be helpful in narrowing the 95% CI, which currently extends
up to a clinically worthwhile 2.7 and down to a clinically trivial 0.9
on the 0–10 scale.
The evidence about TENS had similarities to the evidence about
heat. It was  derived from one small trial; the best estimate of the
effect (ie, 2.3) was similar to the clinically worthwhile threshold;
and the 95% CI extended well above and below this threshold. This
result contradicts that of Proctor et al,9 who  pooled the results
of three studies and concluded that TENS had no statistically sig-
niﬁcant effect, although their analysis was based on the odds of
obtained threshold pain reduction. To achieve the result observed
in our review, Neighbors et al2 delivered TENS at a rate of 1 pulse
per second with pulse width 40 s for 30 minutes. Low-rate TENS
delivered at a frequency of 2 Hz is believed to induce analgesic effect
through an endorphin-mediated mechanism.32
The yoga intervention assessed a set of three simple postures
(cobra, cat, and ﬁsh) executed in a 20-minute session daily during
the luteal phase. The mean reduction in pain (3.2) and the 95% CI
limits (2.2 to 4.2) were all above the clinically worthwhile threshold
of 2.31 However, this result was  derived from a single study with
a PEDro score of 4, so replication of this result in other studies of
yoga and perhaps other exercise regimens should be sought. One
study of a 30-minute walk/jog regimen 3 days per week found a
beneﬁt for dysmenorrhoea,33 although it was  not eligible for this
review because the outcome was  a composite symptom score.
Although the analgesic beneﬁts of heat, TENS, and yoga were
statistically signiﬁcant, the evidence for each intervention came
with minor caveats. All estimates were provided by only a single
trial, the conﬁdence interval did not exclude the possibility that
the effect was  clinically trivial, and the quality of the trial was  low.
However, these interventions have relatively low costs and risks, so
some women  with dysmenorrhoea may  wish to try them despite
these uncertainties.
This systematic review has several strengths. Two reviewers
independently performed study selection, quality assessment, and
data extraction. Statistically signiﬁcant beneﬁts were identiﬁed
for several interventions. Important insights into placebo effects
were identiﬁed by the separation of sham-controlled trials from
trials with no-treatment controls. A possible limitation is that the
search did not include grey literature, which is more likely to report
no statistical signiﬁcance between groups.34,35 This may temper
the positive nature of the evidence of efﬁcacy reported in this
review. Although there was  also potential for language bias, the 13
non-English, non-Swedish articles were excluded for other reasons
esearc
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RR
uring the abstract screening. Therefore, language bias was  not a
imitation. The average PEDro score was within the range we nom-
nated as high quality, and the rarely achieved blinding items on
he PEDro scale were met, with blinding of participants (5 trials),
ssessors (4 trials), and therapists (2 trials).
In conclusion, this review identiﬁed that heat, TENS, and yoga
an each signiﬁcantly reduce the pain of dysmenorrhoea. The mag-
itude of these effects may  or may  not be clinically worthwhile,
ut as the costs and risks of these interventions are low, they could
e considered for clinical use. The review also identiﬁed moderate-
rade evidence to support the use of acupuncture and acupressure,
lthough this may  be due to a placebo effect. Although one study
dentiﬁed a part from spinal manipulation, the weight of evidence
as that it was not effective. Data from further research on these
nd other interventions, such as whole body exercise, could help
o provide more precise estimates of the average effects of physio-
herapy interventions for dysmenorrhoea.
What is already known on this topic: Many  women of
reproductive age experience dysmenorrhea. Although med-
ications are available to treat the pain, these produce side
effects or incomplete pain relief in a substantial propor-
tion of women with dysmenorrhea. Several physiotherapy
interventions have been investigated as non-pharmacological
interventions for dysmenorrhea.
What this study adds: Although acupuncture and acupres-
sure reduced pain severity in dysmenorrhea, this appears to be
a placebo effect. Heat, transcutaneous electrical nerve stimu-
lation, and yoga each signiﬁcantly reduced pain severity, but
spinal manipulation did not.
eAddenda: Figures 3, 5, 7, 9 and 11 and Appendix 1 can be found
nline at doi:10.1016/j.jphys.2013.12.003
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